
### [MONDO:0015999](http://purl.obolibrary.org/obo/MONDO_0015999)
**Label:** primary pigmented nodular adrenocortical disease

**Subclasses:** [MONDO:0012509](http://purl.obolibrary.org/obo/MONDO_0012509) (pigmented nodular adrenocortical disease, primary, 1), [MONDO:0000084](http://purl.obolibrary.org/obo/MONDO_0000084) (pigmented nodular adrenocortical disease), [MONDO:0013616](http://purl.obolibrary.org/obo/MONDO_0013616) (pigmented nodular adrenocortical disease, primary, 3), [MONDO:0012505](http://purl.obolibrary.org/obo/MONDO_0012505) (pigmented nodular adrenocortical disease, primary, 2), [MONDO:0014359](http://purl.obolibrary.org/obo/MONDO_0014359) (pigmented nodular adrenocortical disease, primary, 4), 

**Mapped go classes:** [GO:0045762](http://purl.obolibrary.org/obo/GO_0045762) (positive regulation of adenylate cyclase activity), [GO:0008542](http://purl.obolibrary.org/obo/GO_0008542) (visual learning), [GO:0005952](http://purl.obolibrary.org/obo/GO_0005952) (cAMP-dependent protein kinase complex), [GO:0004862](http://purl.obolibrary.org/obo/GO_0004862) (cAMP-dependent protein kinase inhibitor activity), [GO:0046580](http://purl.obolibrary.org/obo/GO_0046580) (negative regulation of Ras protein signal transduction), [GO:0046069](http://purl.obolibrary.org/obo/GO_0046069) (cGMP catabolic process), [GO:0010737](http://purl.obolibrary.org/obo/GO_0010737) (protein kinase A signaling), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0045859](http://purl.obolibrary.org/obo/GO_0045859) (regulation of protein kinase activity), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0007265](http://purl.obolibrary.org/obo/GO_0007265) (Ras protein signal transduction), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0047555](http://purl.obolibrary.org/obo/GO_0047555) (3',5'-cyclic-GMP phosphodiesterase activity), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0004112](http://purl.obolibrary.org/obo/GO_0004112) (cyclic-nucleotide phosphodiesterase activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0004115](http://purl.obolibrary.org/obo/GO_0004115) (3',5'-cyclic-AMP phosphodiesterase activity), [GO:0004114](http://purl.obolibrary.org/obo/GO_0004114) (3',5'-cyclic-nucleotide phosphodiesterase activity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0016241](http://purl.obolibrary.org/obo/GO_0016241) (regulation of macroautophagy), [GO:0050885](http://purl.obolibrary.org/obo/GO_0050885) (neuromuscular process controlling balance), [GO:0035106](http://purl.obolibrary.org/obo/GO_0035106) (operant conditioning), [GO:0090032](http://purl.obolibrary.org/obo/GO_0090032) (negative regulation of steroid hormone biosynthetic process), [GO:0046676](http://purl.obolibrary.org/obo/GO_0046676) (negative regulation of insulin secretion), [GO:0001403](http://purl.obolibrary.org/obo/GO_0001403) (invasive growth in response to glucose limitation), [GO:0008603](http://purl.obolibrary.org/obo/GO_0008603) (cAMP-dependent protein kinase regulator activity), [GO:0043204](http://purl.obolibrary.org/obo/GO_0043204) (perikaryon), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0097271](http://purl.obolibrary.org/obo/GO_0097271) (protein localization to bud neck), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0005930](http://purl.obolibrary.org/obo/GO_0005930) (axoneme), [GO:0001772](http://purl.obolibrary.org/obo/GO_0001772) (immunological synapse), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0004118](http://purl.obolibrary.org/obo/GO_0004118) (cGMP-stimulated cyclic-nucleotide phosphodiesterase activity), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0008081](http://purl.obolibrary.org/obo/GO_0008081) (phosphoric diester hydrolase activity), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0004691](http://purl.obolibrary.org/obo/GO_0004691) (cAMP-dependent protein kinase activity), [GO:0006198](http://purl.obolibrary.org/obo/GO_0006198) (cAMP catabolic process), [GO:0007005](http://purl.obolibrary.org/obo/GO_0007005) (mitochondrion organization), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0001662](http://purl.obolibrary.org/obo/GO_0001662) (behavioral fear response), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001932](http://purl.obolibrary.org/obo/GO_0001932) (regulation of protein phosphorylation), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0030552](http://purl.obolibrary.org/obo/GO_0030552) (cAMP binding), [GO:0071901](http://purl.obolibrary.org/obo/GO_0071901) (negative regulation of protein serine/threonine kinase activity), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0030553](http://purl.obolibrary.org/obo/GO_0030553) (cGMP binding), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 52.93%
- [GO:0043204](http://purl.obolibrary.org/obo/GO_0043204) (perikaryon) 52.38%
- [GO:0030553](http://purl.obolibrary.org/obo/GO_0030553) (cGMP binding) 52.38%
- [GO:0030552](http://purl.obolibrary.org/obo/GO_0030552) (cAMP binding) 52.38%
- [GO:0008603](http://purl.obolibrary.org/obo/GO_0008603) (cAMP-dependent protein kinase regulator activity) 52.38%
- [GO:0005952](http://purl.obolibrary.org/obo/GO_0005952) (cAMP-dependent protein kinase complex) 52.38%
- [GO:0005930](http://purl.obolibrary.org/obo/GO_0005930) (axoneme) 52.38%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 52.38%
- [GO:0004862](http://purl.obolibrary.org/obo/GO_0004862) (cAMP-dependent protein kinase inhibitor activity) 52.38%
- [GO:0004691](http://purl.obolibrary.org/obo/GO_0004691) (cAMP-dependent protein kinase activity) 52.38%
- [GO:0004118](http://purl.obolibrary.org/obo/GO_0004118) (cGMP-stimulated cyclic-nucleotide phosphodiesterase activity) 52.38%
- [GO:0004115](http://purl.obolibrary.org/obo/GO_0004115) (3',5'-cyclic-AMP phosphodiesterase activity) 52.38%
- [GO:0001772](http://purl.obolibrary.org/obo/GO_0001772) (immunological synapse) 52.38%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 52.38%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 52.38%


